Crescent Graham Number from 2010 to 2026
| CBIO Stock | USD 8.94 0.29 3.14% |
Graham Number | First Reported 2010-12-31 | Previous Quarter 24.15 | Current Value 21.47 | Quarterly Volatility 1.4191952 |
Check Crescent Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Crescent Biopharma's main balance sheet or income statement drivers, such as , as well as many indicators such as Price To Sales Ratio of 1.4 M, Dividend Yield of 0.0 or PTB Ratio of 201. Crescent financial statements analysis is a perfect complement when working with Crescent Biopharma Valuation or Volatility modules.
Crescent | Graham Number | Build AI portfolio with Crescent Stock |
Pair Trading with Crescent Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescent Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescent Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against Crescent Stock
| 0.71 | EQ | Equillium | PairCorr |
| 0.69 | DRTS | Alpha Tau Medical | PairCorr |
| 0.59 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.58 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.54 | PYC | Physiomics Plc | PairCorr |
The ability to find closely correlated positions to Crescent Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescent Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescent Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescent Biopharma to buy it.
The correlation of Crescent Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescent Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescent Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crescent Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Crescent Biopharma Correlation against competitors. To learn how to invest in Crescent Stock, please use our How to Invest in Crescent Biopharma guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Biotechnology sector continue expanding? Could Crescent diversify its offerings? Factors like these will boost the valuation of Crescent Biopharma. Projected growth potential of Crescent fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Crescent Biopharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Crescent Biopharma's market price often diverges from its book value, the accounting figure shown on Crescent's balance sheet. Smart investors calculate Crescent Biopharma's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Crescent Biopharma's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Crescent Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Crescent Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Crescent Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.